Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

incobotulinumtoxinA

Known as: BoNT-A 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
ABSTRACT Introduction: Efficacy and safety of incobotulinumtoxinA in post‐stroke upper‐limb spasticity were studied. Methods… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2014
2014
Typically, botulinum toxin injections for blepharospasm or cervical dystonia (CD) are administered at approximately 3-month… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?
2013
2013
IncobotulinumtoxinA (Xeomin®, NT 201), a preparation without accessory (complexing) proteins, has shown comparable efficacy and… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2013
2013
IncobotulinumtoxinA (Xeomin®, NT 201) is a purified botulinum toxin type A free from accessory (complexing) proteins. Previous… Expand
  • table 2
  • table 1
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2013
2013
BACKGROUND Three botulinum neurotoxin type A preparations (incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA) are… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2012
2012
BACKGROUND IncobotulinumtoxinA and onabotulinumtoxinA are effective treatments for glabellar frown lines, and a dose of 20 U is… Expand
Is this relevant?
Highly Cited
2011
Highly Cited
2011
OBJECTIVE IncobotulinumtoxinA differs from available formulations in that it does not have accessory proteins… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2011
2011
OBJECTIVE To investigate the efficacy and safety of incobotulinumtoxinA (also known as botulinum toxin type A [150 kDa], free… Expand
Is this relevant?
2011
2011
The biological potency of botulinum toxin (BT) drugs is determined by a standardised LD50 assay. However, the potency labelling… Expand
  • table 1
  • table 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Use of botulinum toxin for esthetic purposes has rapidly expanded over the last 20 years. IncobotulinumtoxinA, also… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?